e-learning
resources
Virtual 2020
Pre-Congress Content
Investigations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical importance of centrilobular enfisema in COPD patients: its impact on the BODE index.
R. Plana Bolba (Lleida, Spain), A. Montcusi Moix (Lleida, Spain), S. Santisteve (Lleida, Spain), J. De Torres Tajes (Kingston, Canada), F. Barbe Illa (Lleida, Spain), J. González Gutiérrez (Lleida, Spain)
Source:
Virtual Congress 2020 – Investigations of COPD
Session:
Investigations of COPD
Session type:
E-poster session
Number:
3278
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Plana Bolba (Lleida, Spain), A. Montcusi Moix (Lleida, Spain), S. Santisteve (Lleida, Spain), J. De Torres Tajes (Kingston, Canada), F. Barbe Illa (Lleida, Spain), J. González Gutiérrez (Lleida, Spain). The clinical importance of centrilobular enfisema in COPD patients: its impact on the BODE index.. 3278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The derivation of a new index of severity for COPD patients, the DOSE index: MRC
d
yspnea scale, airflow
o
bstruction,
s
moking status and
e
xacerbations
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007
Can we assess COPD comorbidities by BODE index?
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Is it possible to improve the prediction ability of the BODE index?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Higher BODE Index in COPD patients correlated with higher number of comorbidities
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
The BODE index in patient with COPD in Russia
Source: Eur Respir J 2007; 30: Suppl. 51, 78s
Year: 2007
Pulmonary rehabilitation effects on BODE index in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 70s
Year: 2006
What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET)
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID)
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
The effect of nutritional support on pulmonary rehabilitation outcomes in COPD patients with low body mass index
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
An analysis for neuro-psychiatric symptoms in stable COPD patients and to assess for their correlation with patients‘ characteristics and BODE index
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012
BODE index score changes before and after pulmonary rehabilitation
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Sex differences in mortality in patients with COPD
Source: Eur Respir J 2009; 33: 528-535
Year: 2009
The modified BODE index: validation with mortality in COPD
Source: Eur Respir J 2008; 32: 1269-1274
Year: 2008
Sarcopenia index correlates with COPD clinical outcomes.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept